105 results on '"van Sandick, J.W."'
Search Results
2. Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial
3. The metastatic pattern of intestinal and diffuse type gastric carcinoma – A Dutch national cohort study
4. Nationwide Outcome of Gastrectomy with En-Bloc Partial Pancreatectomy for Gastric Cancer
5. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study
6. Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer
7. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
8. Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study
9. Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy
10. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?
11. Reply to: Comments on “Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy”
12. Oesophageal intestinal metaplasia
13. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study
14. Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial
15. EP-1450: Elevated tumour markers are related to early treatment failure in oesophageal adenocarcinoma
16. EP-1439: MRI-based clinical target volume delineation in gastric cancer: first results of a feasibility study
17. Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit
18. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study
19. Factors contributing to variation in the use of multimodality treatment in patients with gastric cancer: A Dutch population based study
20. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer
21. EP-1246: Definitive chemoradiotherapy for esophageal cancer: the impact of histological subtypes on survival
22. The impact of histological subtype on the prognosis of oesophageal adenocarcinoma
23. Surgicopathological quality control in the CRITICS gastric cancer trial
24. 77. Failure-to-rescue as outcome measure after surgery for esophagogastric cancer
25. 78. Surgicopathological quality control in the CRITICS gastric cancer trial
26. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre)
27. PO-0694: Radiation dose-dependent changes of the spleen following chemoradiotherapy for gastric cancer
28. 604 - The impact of histological subtype on the prognosis of oesophageal adenocarcinoma
29. 7BA - Surgicopathological quality control in the CRITICS gastric cancer trial
30. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.
31. 120. Auditing oesophagogastric cancer treatment in the Netherlands using a composite measure for outcome indicators: Textbook outcome
32. Common data items in seven European oesophagogastric cancer surgery registries: Towards a European Upper GI cancer audit (EURECCA Upper GI)
33. Early detection and surgical treatment of adnocarcinoma of the oesophagus or oesophagogastric junction
34. Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach?
35. Prognostication and prediction using gene expression profiling in oesophageal cancer
36. Barrett-oesofagus en Barrett-carcinoom: reply
37. 101. Quality of care indicators for the surgical treatment of gastric cancer
38. 102. Differences in surgical treatment results of intestinal and diffuse type gastric cancer
39. 443. Diffuse Reflectance Spectroscopy - a New Guidance Tool for Improvement of Biopsy Procedures in Lung Malignancies
40. 120. The outcome of surgical treatment of Gastrointestinal Stromal Tumours (GIST) of the stomach in the Imatinib Era
41. 105. Differences in outcomes and hospital volumes of oesophagogastric cancer surgery across Europe
42. Oesophageal cancer treatment in a tertiary referral hospital evaluated by indicators for quality of care
43. 2157 POSTER Diffuse Reflectance Spectroscopy – a New Guidance Tool for Improvement of Minimal Invasive Procedures in Lung and Liver Cancer
44. Quality-of-care indicators for oesophageal cancer surgery: A review
45. 6566 POSTER Surgical resection for Pancoast tumours after neoadjuvant chemoradiotherapy?
46. Quality of Life After Transhiatal Compared With Extended Transthoracic Resection for Adenocarcinoma of the Esophagus
47. Prognostic factors after potentially curttive transhiatal esophageal resection
48. Early adenocarcinoma of the esophagus and gastroesophageal junction: Pathologic features and outcome after resection
49. Prognostic value of Lauren classification and C-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastro-esophageal junction
50. Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.